Status | Study |
Not yet recruiting |
Study Name: The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2016-04-08 Interventions: Device: Vessix Renal denervation using radio-ablation |
Recruiting |
Study Name: Efficacy of Tolvaptan on ADPKD Patients Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2016-03-11 Interventions: Drug: Tolvaptan |
Recruiting |
Study Name: Contrast-enhanced Ultrasound of the Kidney Condition: Chronic Kidney Disease Cystic Kidney Disease Date: 2016-02-03 Interventions: Drug: Perflutren lipid microsphere Dosing per approved package label |
Recruiting |
Study Name: Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease Condition: Polycystic Kidney, Autosomal Dominant Date: 2015-12-23 Interventions: Drug: Metformin Monitoring of |
Active, not recruiting |
Study Name: Long-Term Treatment and Follow up of Subjects Completing 24 Months of Treatment With Tesevatinib on Study KD019-101 Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Date: 2015-11-24 Interventions: Drug: tesevatinib Other Name: KD019, XL647 |
Recruiting |
Study Name: Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease Condition: Polycystic Kidney Disease Date: 2015-10-30 Interventions: Drug: Pioglitazone Pioglitazon |
Recruiting |
Study Name: Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2) Condition: Polycystic Kidney Disease Date: 2015-09-21 Interventions: Dietary Supplement: Niacinamide |
Recruiting |
Study Name: The German ADPKD Tolvaptan Treatment Registry Condition: ADPKD (Autosomal Dominant Polycystic Kidney Disease) Date: 2015-06-19 |
Recruiting |
Study Name: Evaluation of Complex Renal Cyst With CEUS/Functional MRI Versus CT Condition: Cystic Renal Diseases Kidney Neoplasms Date: 2015-02-19 Interventions: Other: Blood/urine sampling Ro |
Completed |
Study Name: Effect of the Aquaretic Tolvaptan on Nitric Oxide System Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2015-02-18 Interventions: Drug: Tolvaptan 60 mg Tolvapta |